Spravato

Spravato (With Insurance)

A fast-acting, FDA-approved nasal spray for treatment-resistant depression, administered under medical supervision. A typical course of Spravato requires a minimum of 8 sessions.

VISIT TYPE

TREATMENT TYPE

Spravato (With Insurance)

Spravato (Without Insurance)

CONNECT WITH

Add your insurance to activate your benefits,
and shop with upfront prices

Start Your Journey at Hudson Mind

What to Expect

Spravato is an FDA-approved nasal spray for treatment-resistant depression. It works differently from traditional antidepressants by targeting NMDA receptors in the brain, often providing rapid relief. Spravato is administered in a controlled setting under medical supervision to ensure safety and effectiveness.

30%

of people with depression do not respond to antidepressants.

64%

of patients with treatment-resistant depression reported a significant reduction in depressive symptoms after taking Spravato for 3 months.